Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Impact of vector copy number on critical quality attributes of retrovirally engineered T cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 15, 2025
PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial.
Journal: The Lancet. Respiratory medicine
Published: August 06, 2024
Hypertension, smoking, and preexistence of multiple cardiac risk factors correlate with carfilzomib-induced cardiovascular adverse events in a racially diverse population.
Journal: Frontiers in cardiovascular medicine
Published: December 22, 2022
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers.
Journal: Nature medicine
Published: September 16, 2020
T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I/II Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 14, 2019
A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 20, 2018
Showing 1-7 of 7
Last Updated: 09/26/2026